By Jackie Naylor

Age 72 for a long time I'd been getting a rash which disappeared and reappeared daily and I gradually lost the use of my legs. I collapsed at a hospital consultant appointment and was admitted into ICU with septic shock then I was moved onto a ward where I was diagnosed with the very rare autoimmune Adult Onset Stills Disease. I had lost the use of both my arms and legs, was covered in sores, lost half my hair, had blood transfusion, nebulizer and daily IVs and it took a while for the doctors to stabilize me with a multitude of medications.


I contracted Covid in the hospital and was put in an isolation room for 10 days which was excruciating.


I was finally admitted to a Community Hospital where through rehab I have learned to walk again. 


I was in hospital for 14 weeks and its taken the last year to get anywhere near normality having conquered trigger fingers on both hands. I still have painful knees and stiff fingers, low kidney function, AF and have daily injections of Kineret. 


But I can now sew, play the guitar and walk unaided. I still get very fatigued but can't praise the NHS enough for the amazing job in my successful rehabilitation as I'm now in remission 


The first photo is me a month after discharge from hospital


The second and third photos are me today


Kind regards


Jackie Naylor


Person sitting at desk, touching their lower back, likely experiencing pain while working on a laptop.
January 20, 2026
Learn about the latest updates in axial spondyloarthritis research
Green cannabis leaf against a dark green backdrop.
January 20, 2026
Cannabis use among people living with autoimmune and autoinflammatory arthritis (AiArthritis) has quietly shifted from a fringe conversation to a mainstream reality. Patients are using it for pain, sleep, nausea, anxiety, mood, and quality of life—often long before their doctors feel comfortable discussing it.
U.S. Capitol Building dome at dusk, lit from within, with the American flag waving above.
January 15, 2026
AiArthritis commissioned Milliman Insight to analyze newly available hospital reimbursement data for autoimmune drugs. These findings raise important questions about transparency, accountability, and how the 340B program is impacting patients. Discover more.
Four people smiling, posing together inside a restaurant. Wine bottles on the wall, red booth.
January 15, 2026
A recap of the “Go With Us!” Patient-Led Debrief highlighting key takeaways from ACR and EULAR 2025, including early diagnosis, precision medicine, advocacy, mental health, and integrative approaches to AiArthritis disease care.
More Posts